129 related articles for article (PubMed ID: 10586389)
1. The pharmacokinetics of oral ranitidine in children and adolescents with cystic fibrosis.
James LP; Stowe CD; Farrar HC; Menendez AA; Argao EA
J Clin Pharmacol; 1999 Dec; 39(12):1242-7. PubMed ID: 10586389
[TBL] [Abstract][Full Text] [Related]
2. Effects of gender and phase of the menstrual cycle on the kinetics of ranitidine in healthy volunteers.
Flores Pérez J; Juárez Olguín H; Flores Pérez C; Pérez Guillé G; Guillé Pérez A; Camacho Vieyra A; Toledo López A; Carrasco Portugal M; Lares Asseff I
Chronobiol Int; 2003 May; 20(3):485-94. PubMed ID: 12868543
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of ranitidine and nizatidine in very elderly patients.
Sasaki M; Sudoh T; Fujimura A
Am J Ther; 2005; 12(3):223-5. PubMed ID: 15891265
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB).
Lacey LF; Frazer NM; Keene ON; Smith JT
Eur J Clin Pharmacol; 1994; 47(2):177-80. PubMed ID: 7859806
[TBL] [Abstract][Full Text] [Related]
6. A lack of pharmacokinetic interaction between ranitidine and piroxicam.
Dixon JS; Lacey LF; Pickup ME; Langley SJ; Page MC
Eur J Clin Pharmacol; 1990; 39(6):583-6. PubMed ID: 1982764
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of ranitidine in preterm and term neonates with gastroesophageal reflux.
Asseff IL; Gaucin GB; Olguín HJ; Nájera JA; López AT; Guillé GP; Torres FZ
BMC Pediatr; 2016 Jul; 16():90. PubMed ID: 27412521
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis.
Jones KM; Liao E; Hohneker K; Turpin S; Henry MM; Selinger K; Hsyu PH; Boucher RC; Knowles MR; Dukes GE
Pharmacotherapy; 1997; 17(2):263-70. PubMed ID: 9085317
[TBL] [Abstract][Full Text] [Related]
9. Ranitidine, 75 mg, over-the-counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro-oesophageal reflux.
Orenstein SR; Blumer JL; Faessel HM; McGuire JA; Fung K; Li BU; Lavine JE; Grunow JE; Treem WR; Ciociola AA
Aliment Pharmacol Ther; 2002 May; 16(5):899-907. PubMed ID: 11966498
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic ranitidine treatment in critically ill children--a population pharmacokinetic study.
Hawwa AF; Westwood PM; Collier PS; Millership JS; Yakkundi S; Thurley G; Shields MD; Nunn AJ; Halliday HL; McElnay JC
Br J Clin Pharmacol; 2013 May; 75(5):1265-76. PubMed ID: 23016949
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and bioequivalence study of ranitidine film tablets in healthy male subjects.
Gschwend MH; Guserle R; Erenmemişoglu A; Martin W; Tamur U; Kanzik I; Hincal AA
Arzneimittelforschung; 2007; 57(6):315-9. PubMed ID: 17688076
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of famotidine in patients with cystic fibrosis.
Maish WA; McCubbin MM; Letzig LG; Farrar HC; Kearns GL
J Clin Pharmacol; 1998 Nov; 38(11):1010-6. PubMed ID: 9824781
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and bioequivalence of ranitidine and bismuth derived from two compound preparations.
Zhou Q; Ruan ZR; Yuan H; Jiang B; Xu DH
World J Gastroenterol; 2006 May; 12(17):2742-8. PubMed ID: 16718762
[TBL] [Abstract][Full Text] [Related]
14. Effect of age on the pharmacokinetics of ranitidine in healthy Mexican volunteers.
Pérez-Guillé G; Guillé-Pérez A; Toledo-López A; Juárez-Olguín H; Flores Pérez C; Flores-Pŕez J; Carrasco-Portugal M; Lares-Asseff I; Camacho-Vieyra A
Proc West Pharmacol Soc; 2005; 48():84-8. PubMed ID: 16416668
[TBL] [Abstract][Full Text] [Related]
15. Effect of Da-Cheng-Qi decoction on the pharmacokinetics of ranitidine in rats.
Tang WF; Wan MH; Huang QR; Zhu ZY; Zhao JL; Wu YZ; Huang X
Biomed Chromatogr; 2008 Aug; 22(8):851-6. PubMed ID: 18384065
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of ranitidine in neonates treated with extracorporeal membrane oxygenation.
Wells TG; Heulitt MJ; Taylor BJ; Fasules JW; Kearns GL
J Clin Pharmacol; 1998 May; 38(5):402-7. PubMed ID: 9602950
[TBL] [Abstract][Full Text] [Related]
17. Plasma pharmacokinetics of ranitidine HCl in foals.
Holland PS; Brumbaugh GW; Ruoff WW; Brown SA
J Vet Pharmacol Ther; 1997 Dec; 20(6):447-52. PubMed ID: 9430768
[TBL] [Abstract][Full Text] [Related]
18. Ranitidine in children with peptic ulcer and patients with pancreatic cystic fibrosis.
Scorza A; Conti-Nibali S; Sferlazzas C; Saitta G; Tedeschi A
Int J Clin Pharmacol Res; 1990; 10(3):179-82. PubMed ID: 2228343
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of ranitidine in critically ill infants.
Wiest DB; O'Neal W; Reigart JR; Brundage RC; Gillette PC; Yost RL
Dev Pharmacol Ther; 1989; 12(1):7-12. PubMed ID: 2785905
[TBL] [Abstract][Full Text] [Related]
20. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.
Kletzl H; Giraudon M; Ducray PS; Abt M; Hamilton M; Lum BL
Anticancer Drugs; 2015 Jun; 26(5):565-72. PubMed ID: 25643050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
